ALB and colorectal carcinoma: Compared to the Q1 group with respect to serum albumin concentration, the risks of CRC occurrence in the Q2, Q3, and Q4 groups decreased by 12.8% (OR 0.872 [0.784-0.971], p=0.012), 11.7% (OR 0.883, 95% CI [0.792-0.983], p=0.024), and 12.3% (OR 0.877, 95% CI [0.786-0.979], p=0.020).